119 related articles for article (PubMed ID: 31589305)
1. Perioperative Infusion of Glucagon-Like Peptide-1 Prevents Insulin Resistance After Surgical Trauma in Female Pigs.
Hagve M; Gjessing PF; Hole MJ; Jansen KM; Fuskevåg OM; Mollnes TE; Larsen TS; Irtun Ø
Endocrinology; 2019 Dec; 160(12):2892-2902. PubMed ID: 31589305
[TBL] [Abstract][Full Text] [Related]
2. Study protocol of a randomised controlled trial comparing perioperative intravenous insulin, GIK or GLP-1 treatment in diabetes-PILGRIM trial.
Polderman JA; Houweling PL; Hollmann MW; DeVries JH; Preckel B; Hermanides J
BMC Anesthesiol; 2014; 14():91. PubMed ID: 25419179
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
4. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
[TBL] [Abstract][Full Text] [Related]
5. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2012 Apr; 97(4):1363-70. PubMed ID: 22319034
[TBL] [Abstract][Full Text] [Related]
6. Single-dose carbohydrate treatment in the immediate preoperative phase diminishes development of postoperative peripheral insulin resistance.
Gjessing PF; Hagve M; Fuskevåg OM; Revhaug A; Irtun Ø
Clin Nutr; 2015 Feb; 34(1):156-64. PubMed ID: 24656290
[TBL] [Abstract][Full Text] [Related]
7. Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways.
Nishizawa M; Nakabayashi H; Uehara K; Nakagawa A; Uchida K; Koya D
Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E376-87. PubMed ID: 23715725
[TBL] [Abstract][Full Text] [Related]
8. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.
Knauf C; Cani PD; Perrin C; Iglesias MA; Maury JF; Bernard E; Benhamed F; Grémeaux T; Drucker DJ; Kahn CR; Girard J; Tanti JF; Delzenne NM; Postic C; Burcelin R
J Clin Invest; 2005 Dec; 115(12):3554-63. PubMed ID: 16322793
[TBL] [Abstract][Full Text] [Related]
9. Vasodilatory Actions of Glucagon-Like Peptide 1 Are Preserved in Skeletal and Cardiac Muscle Microvasculature but Not in Conduit Artery in Obese Humans With Vascular Insulin Resistance.
Wang N; Tan AWK; Jahn LA; Hartline L; Patrie JT; Lin S; Barrett EJ; Aylor KW; Liu Z
Diabetes Care; 2020 Mar; 43(3):634-642. PubMed ID: 31888883
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of glucagon-like peptide-1 on microvascular recruitment and glucose metabolism in short- and long-term insulin resistance.
Sjøberg KA; Rattigan S; Jeppesen JF; Lundsgaard AM; Holst JJ; Kiens B
J Physiol; 2015 May; 593(9):2185-98. PubMed ID: 25688993
[TBL] [Abstract][Full Text] [Related]
11. Hyperinsulinemic euglycemic step clamping with tracer glucose infusion and labeled glucose infusate for assessment of acute insulin resistance in pigs.
Gjessing PF; Fuskevåg OM; Hagve M; Revhaug A; Irtun Ø
Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1305-12. PubMed ID: 20371732
[TBL] [Abstract][Full Text] [Related]
12. Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region.
Dardevet D; Moore MC; Neal D; DiCostanzo CA; Snead W; Cherrington AD
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E75-81. PubMed ID: 15026303
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide 1 recruits muscle microvasculature and improves insulin's metabolic action in the presence of insulin resistance.
Chai W; Zhang X; Barrett EJ; Liu Z
Diabetes; 2014 Aug; 63(8):2788-99. PubMed ID: 24658303
[TBL] [Abstract][Full Text] [Related]
14. The GLP-1 analogue exenatide improves hepatic and muscle insulin sensitivity in diabetic rats: tracer studies in the basal state and during hyperinsulinemic-euglycemic clamp.
Wu H; Sui C; Xu H; Xia F; Zhai H; Zhang H; Weng P; Han B; Du S; Lu Y
J Diabetes Res; 2014; 2014():524517. PubMed ID: 25580440
[TBL] [Abstract][Full Text] [Related]
15. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1085-91. PubMed ID: 17684104
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus.
McCormick LM; Heck PM; Ring LS; Kydd AC; Clarke SJ; Hoole SP; Dutka DP
Cardiovasc Diabetol; 2015 Aug; 14():102. PubMed ID: 26253538
[TBL] [Abstract][Full Text] [Related]
17. GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet.
Parlevliet ET; de Leeuw van Weenen JE; Romijn JA; Pijl H
Am J Physiol Endocrinol Metab; 2010 Aug; 299(2):E318-24. PubMed ID: 20530733
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.
Egan JM; Meneilly GS; Habener JF; Elahi D
J Clin Endocrinol Metab; 2002 Aug; 87(8):3768-73. PubMed ID: 12161508
[TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle mitochondria exhibit decreased pyruvate oxidation capacity and increased ROS emission during surgery-induced acute insulin resistance.
Hagve M; Gjessing PF; Fuskevåg OM; Larsen TS; Irtun Ø
Am J Physiol Endocrinol Metab; 2015 Apr; 308(8):E613-20. PubMed ID: 25670828
[TBL] [Abstract][Full Text] [Related]
20. Insulinotropic hormone glucagon-like peptide-1-(7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia.
Ryan AS; Egan JM; Habener JF; Elahi D
J Clin Endocrinol Metab; 1998 Jul; 83(7):2399-404. PubMed ID: 9661618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
